Publications by authors named "Jason L Bandy"

Claim this Profile
T
Tofacitinib: The First Janus Kinase (JAK) inhibitor for the treatment of rheumatoid arthritis.
Deepti Vyas, Kate M O'Dell, Jason L Bandy, Eric G Boyce

Ann Pharmacotherยท November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis